“Real-World Effectiveness of Tralokinumab in Adults With Atopic Dermatitis: Interim Data on Improvements in Patients With Head and Neck Atopic Dermatitis After up to 9 Months of Treatment in the TRACE Study”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 2, Mar. 2025, p. s574, https://doi.org/10.25251/skin.10.supp.574.